Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by cash on hand, at NOK 190.8B, ahead of Merck & Co (NOK 141B) and Novartis (NOK 110.7B). Figures as of 18 Nov 2026, 22:51 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonNOK 190.8B
- Median
- NOK 5.5B
- Combined market value
- NOK 48.97T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | NOK 190.8B | NOK 6.35T | NOK 2,639.49 | 2.15% down | 38% up | ||
| 2 | Merck & CoMRK · Health Care | NOK 141B | NOK 3.29T | NOK 1,333.59 | 3.90% down | 51% up | ||
| 3 | NovartisNVS · Health Care | NOK 110.7B | NOK 2.84T | NOK 1,502.29 | 2.46% down | 25% up | ||
| 4 | Bristol-Myers SquibbBMY · Health Care | NOK 98.8B | NOK 1.18T | NOK 576.49 | 2.92% down | 34% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | NOK 82.5B | NOK 1.75T | NOK 1,011.27 | 0.22% down | 17% down | ||
| 6 | SanofiSNY · Health Care | NOK 82.2B | NOK 1.1T | NOK 456.08 | 0.86% down | 4% down | ||
| 7 | Eli LillyLLY · Health Care | NOK 70.3B | NOK 11.92T | NOK 13,383.78 | 2.32% down | 35% up | ||
| 8 | AstraZenecaAZN · Health Care | NOK 55.3B | NOK 2.68T | NOK 1,730.24 | 1.93% down | 2% up | ||
| 9 | AbbVieABBV · Health Care | NOK 50.6B | NOK 4.89T | NOK 2,768.32 | 2.33% down | 26% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | NOK 49.2B | NOK 1.32T | NOK 5,192.35 | 0.42% up | 27% up | ||
| 11 | BeOne MedicinesONC · Health Care | NOK 44B | NOK 446.2B | NOK 3,906.48 | 2.34% down | 17% up | ||
| 12 | GSKGSK · Health Care | NOK 43.6B | NOK 942.5B | NOK 470.21 | 1.34% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | NOK 38B | NOK 1.68T | NOK 381.65 | 3.12% down | 17% down | ||
| 14 | Takeda PharmaceuticalTAK · Health Care | NOK 36.1B | NOK 657.7B | NOK 205.87 | 1.71% down | 54% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | NOK 34.4B | NOK 476.9B | NOK 408.75 | 0.92% down | 74% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | NOK 30.2B | NOK 946.7B | NOK 9,151.88 | 1.28% down | 36% up | ||
| 17 | ZoetisZTS · Health Care | NOK 22.4B | NOK 336.5B | NOK 828.24 | 2.50% up | 29% down | ||
| 18 | GenmabGMAB · Health Care | NOK 16.6B | NOK 304.2B | NOK 493.34 | 1.91% down | 70% up | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | NOK 16B | NOK 193.7B | NOK 1,446.06 | 4.54% down | 66% down | ||
| 20 | United TherapeuticsUTHR · Health Care | NOK 15.1B | NOK 238B | NOK 5,588.13 | 1.16% down | 23% up | ||
| 21 | Roivant SciencesROIV · Health Care | NOK 13.7B | NOK 271.6B | NOK 374.87 | 0.05% up | 90% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | NOK 13.5B | NOK 153.9B | NOK 2,398.19 | 2.93% up | 37% up | ||
| 23 | ViatrisVTRS · Health Care | NOK 12.8B | NOK 225B | NOK 196.29 | 0.83% down | 96% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | NOK 12.7B | NOK 115.2B | NOK 594.59 | 4.99% up | 11% up | ||
| 25 | PfizerPFE · Health Care | NOK 11.1B | NOK 1.55T | NOK 271.60 | 1.44% down | 14% up | ||
| 26 | PTC TherapeuticsPTCT · Health Care | NOK 9.5B | NOK 48.7B | NOK 582.97 | 0.22% down | 20% down | ||
| 27 | GrifolsGRFS · Health Care | NOK 8.9B | NOK 55.8B | NOK 81.98 | 1.85% down | 1% up | ||
| 28 | Legend BiotechLEGN · Health Care | NOK 8.7B | NOK 30.5B | NOK 157.29 | 0.87% up | 42% down | ||
| 29 | Ascendis PharmaASND · Health Care | NOK 6.6B | NOK 171.6B | NOK 2,616.55 | 0.32% down | 28% up | ||
| 30 | Royalty PharmaRPRX · Health Care | NOK 6B | NOK 382.2B | NOK 664.66 | 0.01% down | 78% up | ||
| 31 | ABIVAXABVX · Health Care | NOK 5.5B | NOK 71B | NOK 811.40 | 2.11% up | 27% down | ||
| 32 | BridgeBio PharmaBBIO · Health Care | NOK 5.5B | NOK 147.1B | NOK 755.07 | 1.58% up | 17% up | ||
| 33 | Elanco Animal HealthELAN · Health Care | NOK 5.3B | NOK 129.2B | NOK 258.43 | 3.29% up | 20% up | ||
| 34 | InsmedINSM · Health Care | NOK 4.9B | NOK 254.4B | NOK 1,159.56 | 1.69% down | 40% down | ||
| 35 | AlkermesALKS · Health Care | NOK 3.8B | NOK 76.2B | NOK 453.47 | 3.08% up | 58% up | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | NOK 3.6B | NOK 44.2B | NOK 265.11 | 1.59% up | 64% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | NOK 3.5B | NOK 82.6B | NOK 2,953.96 | 0.04% up | 61% up | ||
| 38 | Belite BioBLTE · Health Care | NOK 3.4B | NOK 61.4B | NOK 1,512.17 | 0.94% down | 31% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | NOK 3.1B | NOK 68.2B | NOK 1,297.00 | 1.43% down | 7% down | ||
| 40 | Cogent BiosciencesCOGT · Health Care | NOK 3B | NOK 46.8B | NOK 269.18 | 0.14% down | 20% down | ||
| 41 | Mirum PharmaceuticalsMIRM · Health Care | NOK 2.9B | NOK 58.4B | NOK 895.22 | 0.59% up | 31% up | ||
| 42 | Amneal PharmaceuticalsAMRX · Health Care | NOK 2.7B | NOK 73.8B | NOK 211.78 | 3.60% up | 83% up | ||
| 43 | Definium TherapeuticsDFTX · Health Care | NOK 2.5B | NOK 38.6B | NOK 281.86 | 0.88% down | 169% up | ||
| 44 | Arrowhead PharmaceuticalsARWR · Health Care | NOK 2.2B | NOK 59B | NOK 417.27 | 0.28% up | 10% up | ||
| 45 | Summit TherapeuticsSMMT · Health Care | NOK 2.2B | NOK 81.3B | NOK 101.63 | 1.59% down | 36% down | ||
| 46 | Madrigal PharmaceuticalsMDGL · Health Care | NOK 1.9B | NOK 89.5B | NOK 3,853.06 | 5.67% down | 24% down | ||
| 47 | Ligand PharmaceuticalsLGND · Health Care | NOK 1.7B | NOK 57.8B | NOK 2,891.24 | 1.67% up | 43% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 1.6B | NOK 72.3B | NOK 920.00 | 0.06% down | 126% up | ||
| 49 | Dr. Reddy's LaboratoriesRDY · Health Care | NOK 1.6B | NOK 120.9B | NOK 144.99 | 1.28% up | 5% up | ||
| 50 | Protagonist TherapeuticsPTGX · Health Care | NOK 1.2B | NOK 80.3B | NOK 1,230.79 | 2.00% up | 46% up | ||
| 51 | CytokineticsCYTK · Health Care | NOK 1.2B | NOK 69.2B | NOK 496.73 | 0.64% down | 20% down | ||
| 52 | Corcept TherapeuticsCORT · Health Care | NOK 1.2B | NOK 71.8B | NOK 656.15 | 3.25% down | 8% down | ||
| 53 | Travere TherapeuticsTVTX · Health Care | NOK 900.5M | NOK 46.7B | NOK 486.28 | 1.68% down | 44% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | NOK 829.7M | NOK 93.3B | NOK 982.04 | 8.15% up | 286% up | ||
| 55 | TG TherapeuticsTGTX · Health Care | NOK 766.1M | NOK 96.7B | NOK 639.98 | 5.44% up | 107% up | ||
| 56 | ErascaERAS · Health Care | NOK 714.4M | NOK 46.7B | NOK 133.18 | 0.94% down | 403% up | ||
| 57 | Edgewise TherapeuticsEWTX · Health Care | NOK 591.9M | NOK 43.8B | NOK 400.42 | 1.59% down | 88% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | NOK 525.6M | NOK 79.9B | NOK 1,152.20 | 2.08% up | 13% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | NOK 494.5M | NOK 45.8B | NOK 812.85 | 3.45% down | 113% up | ||
| 60 | Oruka TherapeuticsORKA · Health Care | NOK 454.3M | NOK 62.8B | NOK 926.68 | 0.60% down | 241% up | ||
| 61 | VeradermicsMANE · Health Care | NOK 210.7M | NOK 51B | NOK 1,208.53 | 0.62% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6791 NOK).
Questions and answers
Which pharmaceutical companies rank first by cash on hand?
Johnson & Johnson (NOK 190.8B), Merck & Co (NOK 141B) and Novartis (NOK 110.7B) are the top three of the 61 pharmaceutical companies ranked by cash on hand as of 18 Nov 2026, 22:51 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of NOK 48.97T as of 18 Nov 2026, 22:51 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.